Ross is the Managing General Partner of the Cancer Focus Fund, LP. He has started and overseen several VC funds, and is co-founder of a data analytics firm that tracks venture-backed firms. [More]

Jonathan Fassberg is co-founder and Managing Partner at astr partners, an exclusive network purpose-built to support life science investors and their priority portfolio companies. [More]

David Epstein serves on the Healthcare Advisory Board of J.P. Morgan Life Sciences Private Capital. He was CEO of Seagen before its sale to Pfizer in December 2023. [More]

Head of Life Sciences and Co-Head of Healthcare Investment Banking at Oppenheimer & Co. [More]

Jennifer’s responsibilities at CFF include performing financial modeling and analysis, assisting the Investment Committee with their due diligence process and managing communication with investors. [More]

Dr. Alila has more than 30 years of senior management experience in drug development in large pharmaceutical and biotech companies and academic research. [More]

Jaime Aguirre is the Chief Investment Officer of Atlas Capital Global, and an independent advisor to a Mexican pension fund with over $50 billion in assets. [More]

Avery is an Investor Relations Analyst for the Cancer Focus Fund. Her responsibilities include playing a critical role in supporting the firm’s fundraising efforts and maintaining strong relationships with our limited partners. [More]